HCA Healthcare, Inc. reported results for the second quarter of 2026 with revenue of $20.23B and diluted EPS of $7.62, versus $18.61B in revenue and $6.83 EPS in Q2 2025. Net income attributable to HCA Healthcare, Inc. was $1.699B, up modestly year over year.Financial HighlightsBusiness HighlightsO…
Hamilton Capital Partners Inc. (“Hamilton ETFs”) is pleased to announce the upcoming monthly and semi-monthly cash distributions for its ETFs.Distributions may vary from period to period.Table A includes the Hamilton ETFs that pay monthly cash distributions, all of which trade on the Toronto Stock…
Q2 saw 11% EPS growth and strong insured volume, but a 15% drop in exchange patients led to a rise in uninsured volumes and a $400M EBITDA headwind, offset by Medicaid payments. 2026 guidance reflects these shifts, with revenue of $77–$79.5B and continued investment in capacity.Based on HCA Healthc…
Q2 saw 11% EPS growth and strong demand, but a sharp payer mix shift from exchange attrition led to higher uninsured volumes and pressured margins. Medicaid supplemental payments and cost controls offset some headwinds, while guidance was revised to reflect these dynamics.Based on HCA Healthcare, I…
Q2 2026 saw 8.7% revenue growth and 2.8% higher net income, but payer mix shifts and lower surgical volumes pressured margins. Updated 2026 guidance reflects higher negative impact from uninsured volumes, partially offset by Medicaid program benefits.Original document: HCA Healthcare, Inc. [HCA] SE…
HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026.The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview.Key second qua…
Hospital operator HCA Healthcare NYSE:HCAwill be announcing earnings results this Friday morning. Here’s what to expect.HCA Healthcare met analysts’ revenue expectations last quarter, reporting revenues of $19.11 billion, up 4.3% year on year. It was a mixed quarter for the company, with EPS in lin…
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or “the Company”) (NYSE: HCA) for violations of the securities laws.The investigation focuses on whether the Company issued false and/o…
HCA Healthcare, Inc. HCA is making significant investments to expand its healthcare network, reinforcing capacity growth as a core component of its long-term strategy. Despite short-term pressure on patient volumes, it continues to add hospital beds, expand emergency room capacity and selectively a…
